Eiger BioPharmaceuticals to Present at BIO CEO & Investor Conference February 13th and Participate in SunTrust Robinson Humphrey Orphan Drug Day Conference February 14th
A live webcast of the presentation will be available on the
Eiger will also host one-on-one meetings with investors at the SunTrust Robinson Humphrey 2017 Orphan Drug Day conference on
About Eiger
Eiger is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare diseases. The company has built a diverse portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which an effective therapy is urgently needed. For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Investors:
[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-present-at-bio-ceo--investor-conference-february-13th-and-participate-in-suntrust-robinson-humphrey-orphan-drug-day-conference-february-14th-300398543.html
SOURCE